Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tagliati, M.
Right arrow Articles by Simpson, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tagliati, M.
Right arrow Articles by Simpson, D. M.
Neurology 2000;54:1477-1482
© 2000 American Academy of Neurology


Articles

The role of somatosensory evoked potentials in the diagnosis of AIDS-associated myelopathy

Michele Tagliati, MD, Alessandro Di Rocco, MD, Fabio Danisi, MD and David M. Simpson, MD

From the Department of Neurology (Drs. Tagliati, Danisi, and Simpson), and Clinical Neurophysiology (Drs. Tagliati and Simpson), The Mount Sinai Medical Center, New York, NY; and the Department of Neurology (Dr. Di Rocco), Beth Israel Medical Center, Albert Einstein College of Medicine, New York, NY.

Address correspondence and reprint requests to Dr. Michele Tagliati, Department of Neurology, Beth Israel Medical Center, PACC, Suite 2R, 10 Union Square East, New York, NY 10003; e-mail: mtagliat{at}bethisraelny.org

BACKGROUND: Although AIDS-associated vacuolar myelopathy is detected in >50% of autopsy cases, it is often unrecognized during life. The clinical assessment is often difficult because of concurrent peripheral neuropathy and lack of specific diagnostic markers. Somatosensory evoked potentials (SEPs) have been successfully used to evaluate central conduction in a number of diseases involving the spinal cord.

OBJECTIVES: To assess the diagnostic yield of SEPs in AIDS-associated myelopathy.

METHODS: We recorded tibial and median nerve SEPs in 69 HIV-infected subjects referred for evaluation of lower extremity neurologic abnormalities. Stimulation of the peroneal nerve at the popliteal fossa was performed in patients with absent response to ankle stimulation.

RESULTS: HIV-infected subjects had significantly delayed latencies of both peripheral and central potentials, suggesting a combination of peripheral and CNS abnormalities. Analysis of peripheral and central latencies allowed us to discriminate between neuropathy and myelopathy in individual patients. Abnormalities of tibial central conduction time (CCT) correlated with clinical diagnosis of myelopathy. There was no significant difference in median CCTs between patients and controls, suggesting that conduction abnormalities were restricted to the thoracolumbar spinal cord. A derived spinal conduction time was a sensitive indicator of central conduction abnormalities in AIDS patients with myelopathy.

CONCLUSIONS: The combination of median, posterior tibial, and peroneal SEPs is a valuable tool in the diagnosis of AIDS-associated myelopathy, particularly when myelopathy and peripheral neuropathy coexist. The use of a derived spinal conduction time improves the diagnostic yield of SEPs in AIDS-associated myelopathy.

Key words: HIV—AIDS—Myelopathy—Somatosensory evoked potentials




This article has been cited by other articles:


Home page
NeurologyHome page
A. Di Rocco, P. Werner, T. Bottiglieri, J. Godbold, M. Liu, M. Tagliati, A. Scarano, and D. Simpson
Treatment of AIDS-associated myelopathy with L-methionine: A placebo-controlled study
Neurology, October 12, 2004; 63(7): 1270 - 1275.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Di Rocco, T. Bottiglieri, P. Werner, A. Geraci, D. Simpson, J. Godbold, and S. Morgello
Abnormal cobalamin-dependent transmethylation in AIDS-associated myelopathy
Neurology, March 12, 2002; 58(5): 730 - 735.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Di Rocco, A. Geraci, M. Tagliati, R. Staudinger, and K. Henry
Remission of HIV myelopathy after highly active antiretroviral therapy
Neurology, August 8, 2000; 55(3): 456 - 456.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by AAN Enterprises, Inc.